Eric is a man of the right
kidney.
埃里克是个脾气很好的人。
Tom's father died of
kidney failure.
汤姆的父亲死于肾衰竭。
Tony had
kidney stones.
托尼有肾结石。
The investment was announced at an industry conference about the comprehensive prevention and control of hypertension, hyperlipidemia and hyperglycemia as well as three major chronic diseases: chronic heart failure, chronic kidney disease, and chronic obstructive pulmonary disease.
这项投资是在一次关于高血压、高脂血症和高血糖以及三大慢性病（慢性心力衰竭、慢性肾脏病和慢性阻塞性肺病）综合防治的行业会议上宣布的。
IgAN patients are at risk of progressing to end-stage renal disease, which often requires dialysis or a kidney transplant.
IgAN患者有发展为终末期肾病的风险，这通常需要透析或肾移植。
Besides, several of its innovative products in the areas of autoimmune, cardiovascular and kidney diseases as well as diabetes have been included in the latest version of the National Reimbursement Drug List.
此外，其在自身免疫、心血管和肾脏疾病以及糖尿病领域的一些创新产品已被列入最新版本的国家报销药物清单。
In November, China approved the first rare disease therapy from AstraZeneca, bringing innovative treatment options to paroxysmal nocturnal hemoglobinuria and atypical hemolytic-uremic syndrome, two diseases related to kidney and blood vessel malfunctions in adults and children.
11月，中国批准了阿斯利康的首个罕见病疗法，为阵发性夜间血红蛋白尿和非典型溶血性尿毒症综合征这两种与成人和儿童肾脏和血管功能紊乱有关的疾病带来了创新的治疗选择。
In addition, the market launch of Kerendia™ for the treatment of patients with chronic kidney disease and type 2 diabetes during the third quarter of 2021 had a positive impact.
此外，2021年第三季度，用于治疗慢性肾脏疾病和2型糖尿病患者的Kerendia™的市场推出产生了积极影响。
These patients include the elderly and people with chronic kidney or lung issues, cardiovascular disease, diabetes and other high-risk factors.
这些患者包括老年人和患有慢性肾脏或肺部问题、心血管疾病、糖尿病和其他高危因素的人。
"All divisions successfully launched innovations last year, with Baumann naming the Kerendia™ kidney disease drug, Intacta 2 Xtend™ soybean seeds and the Bepanthen™ Derma skincare product as examples.
“去年，所有部门都成功推出了创新，Baumann以Kerendia™肾病药物、Intacta 2 Xtend™大豆种子和Bepanhen™Derma护肤品为例。
Meanwhile, Medtronic is exhibiting more than 60 world-class medical technology innovations that cover a wide variety of fields such as heart and blood vessels, innovative surgery, smart medicine, nerve and spine surgery, digestion and liver, kidney health, and critical medicine.
与此同时，美敦力正在展示60多项世界级的医疗技术创新，涵盖心脏和血管、创新外科、智能医学、神经和脊柱外科、消化和肝脏、肾脏健康以及重症医学等广泛领域。
These exhibits will cover seven areas, namely, heart and blood vessels, innovative surgery, smart medicine, nerve and spine surgery, digestion and liver, kidney health, and critical medicine, and will display global medical technology trends of intelligence, digitalization, and minimal invasiveness, said the company.
Multinational pharmaceutical AstraZeneca and the China Association of Health Promotion and Education have joined hands on the establishment of Chronic Kidney Disease Integrated Management Center in Zhengzhou, Henan province, a project aiming to foster the development of a three-tier system involving national, regional, and primary networks, and promote the standardization of integrated care for patients with chronic kidney disease.
The center was established under the guidance of Liu Zhihong, director of the National Clinical Research Center of Kidney Diseases, Jinling Hospital, and academician of the Chinese Academy of Engineering.
The center will prioritize disease prevention, while facilitating early-stage screening, standardized diagnosis and treatment, and long-term management, aiming to further improve the prognosis of patients with chronic kidney disease, delay disease progression, and improve the quality of life for patients and their families, so as to finally meet the desire of patients with chronic kidney disease to pursue a better life, the company said.
According to Liu, the incidence of chronic kidney disease in China is about 10.8 percent, and the set-up of a national comprehensive system for the prevention and treatment of chronic kidney disease will help effectively manage patients with chronic kidney disease and achieve overall screening of high-risk populations.
In the traditional diagnosis and treatment of chronic kidney disease, due to the unnoticed onset and low awareness rate, most patients with chronic kidney disease are often diagnosed in late stage, thus causing irreversible damage.
To address unmet treatment needs, the center will provide an efficient and convenient one-stop integrated management solution, so that patients can be identified through screening in the early stage, and receive timely standardized treatment and effective whole-process management, together with reduced risks of dialysis and kidney transplantation, lower overall costs and eased disease burden.
Based on the three-tier mechanism that links the national center, core medical institutions and primary networks, the center will effectively support the strategy for chronic kidney disease management, and help realize early detection, effective prevention and control, and standardized diagnosis and treatment of chronic kidney disease in China.
Michael Lai, general manager of AstraZeneca China, said: "China has a huge number of patients with chronic kidney disease, who are in urgent need of innovative treatment and management solutions.
"We will join hands with our partners to build the chronic kidney disease management center, and step up efforts to create the most professional industry platform in the field of nephrology.
"We aim to advance standardized treatment of chronic kidney disease in China, and make joint efforts to help realize the dream of kidney disease patients to pursue a better life. "
RDPAC companies are leveraging digital healthcare tools to provide disease management services, medication guidance, online consultations, and drug deliveries to patients with life-threatening diseases such as cancer, kidney problems, and severe immunological diseases who are facing difficulties getting critical treatments and medications due to the epidemic.
The Chinese entrepreneur won the auction for this year's Buffett lunch with a record high $4.57 million bid in June, while he canceled the planned lunch meeting, claiming he had "a sudden kidney stone attack" in a Tuesday post on Weibo.
Chinese entrepreneur Sun Yuchen canceled Thursday's lunch meeting with US business magnate Warren Buffett due to a sudden kidney stone attack, Sun announced via his Sina Weibo account early Tuesday morning.
The program will focus on innovative treatments for diabetes and other chronic conditions the company specializes in, such as obesity, cardiovascular and chronic kidney diseases.
According to the NMPA approval, roxadustat is to be used in the treatment of anemia caused by chronic kidney disease (CKD) in patients who are dialysis-dependent (DD).
The development of roxadustat ends a long period in which there were no new drugs developed by a new mechanism for the treatment of CKD-caused anemia, said Chen Xiangmei, member of the Chinese Academy of Engineering and head of the PLA Institute of Kidney Diseases.
Novartis Group China, an affiliate of the Swiss healthcare giant, is displaying its groundbreaking medicines and technologies at CIIE, including a number of innovative medicines for heart failure, respiratory disease, blood diseases, lung cancer, kidney cancer and breast cancer.
The company inked a licensing agreement with Japanese EA Pharmaceutical Co Ltd on Wednesday, giving it the rights to develop, produce and commercialize EA's new kidney disease treatment medicine, a drug that treats enlargement of one or more of the parathyroid glands caused by end-stage renal impairment and dialysis.
Votrient is for a form of kidney cancer called advanced renal cell carcinoma and the medicine Jakavi is for myelofibrosis, a bone marrow condition.
Furthermore, the report showed that functional rice varieties such as blackberry rice rich in anthocyanin, low-glycemic-index rice for diabetics and low-protein rice for those with kidney ailments are inevitable trends.
The move reflects the project's efforts to protect the ecology around Baiyangdian Lake near the area, the largest freshwater lake in North China often referred to as the Kidney of North China.
Like Guangzhou Yuanbo, Tianjin-based animal health company Ringpu Biotech has long been investing in veterinary drugs, vaccines, third-party testing institutions and pet hospitals, while Luoyang, Henan province-based high-tech enterprise Pulike Bio-engineering has received approval for a variety of products including internal and external pet deworming drugs, drugs for feline chronic kidney diseases and animal ear medicines.
Among them are medications for common and chronic diseases such as hypertension, diabetes and digestive disease, as well as serious disorders like lung, liver, kidney and intestinal cancers.
"The official highlighted kidney beans and quinoa, saying their outputs and planting area take up more than 80 percent of the provincial total and more than one-third of the national total.
Wang noted that Xinzhou is home to a number of products with geographical indications, including Xinzhou's sticky corn, yellow millet from Fansi county, naked oats from Ningwu county and red kidney beans from Wuzhai county.
The county is now the largest exporter of red kidney beans in China, with an annual export volume of more than 10,000 tons in recent years, according to local officials.
In the field of immunology, the company said it has eight clinical trials in different phases, covering illnesses such as Crohn's disease－an inflammation of the bowel－the skin disease psoriasis and lupus nephritis, a kidney condition brought on by the autoimmune disease lupus.
The fruit is believed to have health benefits such as protecting the eyes, stabilizing blood sugar levels and preventing liver and kidney damage.
In 2008, domestic dairy giant Sanlu Group was involved in a major scandal due to its contaminated milk powder, which sickened over 1,000 babies with kidney stones, leaving two dead.
Sanlu's baby formula was determined to contain melamine, a chemical believed to cause kidney stones in toddlers.
To date, more than 30 diseases including diabetes, chronic kidney disease and several types of cancer and mental conditions have been covered.
The program will provide free Roxadustat capsules, the world's first-in-class new drug for the treatment of anemia caused by chronic kidney disease in patients who are dialysis-dependent, a major breakthrough for 30 years in the treatment of anemia.
As the diabetic population in China continues to rise, if interventions are not appropriately implemented among the population, the prevalence of end-stage renal disease will peak within 10 to 20 years, due to the growth of diabetic kidney disease patients, bringing an unbearable disease burden to China's healthcare system, according to a report released by the National Institute of Health Data Science at Peking University.
About 21.3 percent of Chinese diabetic patients have chronic kidney disease, and it is estimated there are about 24.3 million patients with diabetic kidney disease in China.
It is urgent to promote the establishment of a national kidney disease surveillance system based on existing multisource databases, and use big data to bring new opportunities for the monitoring and management of kidney disease, the report suggested.
Chronic kidney disease patients in China have obvious regional and urban-rural differences, and it is necessary to strengthen kidney specialist resources and related medical services in primary hospitals, as well as accelerate the construction of regional kidney disease clinics, it said.
According to the report, among hospitalized patients with chronic kidney disease, a larger proportion of them are men and over 50 percent of the total are under 60 years old.
The median hospitalization cost for hospitalized patients with chronic kidney disease is 30 percent higher than that of patients with nonchronic kidney disease.
Chronic kidney disease is closely related to cardiovascular and cerebrovascular diseases.
About 18.2 percent of chronic kidney disease patients have coronary heart disease, and the figures for patients with heart failure and stroke are respectively 16 percent and 12.9 percent.
In December, the National Medical Products Administration approved Roxadustat, a drug developed by AstraZeneca and FibroGen, as a new treatment for anemia caused by chronic kidney disease in patients dependent on dialysis.
Last month, China became the first country to approve Roxadustat, a first-in-class treatment for anemia caused by chronic kidney disease in patients who are dialysis-dependent, co-developed by AstraZeneca China and FibroGen China.
Roxadustat, a domestically developed first-in-class Class 1 medicine, has received approval from the National Medical Products Administration, making China the first country that has greenlighted the oral medicine used for treatment of anemia caused by chronic kidney disease.
The larger "double kidney" grille has adopted an inverted trapezoid design and the BMW adaptive hexagonal LED headlamps are equipped on the X model for the first time.
The Dark Edition brings black mirror caps, a black M performance kidney grille, dark front and rear lights, dark wheel rims, sport seats and a M Sport Package steering wheel as standard.
The air stream kidney grille contributes to aerodynamics and increases efficiency.
"The green revolution is undoubtedly taking place, and the newly released standards made by China and the EU have shown the global market's great progress in sustainable investment," said Sean Kidney, the CBI's CEO and co-founder.
He announced cancellation of the lunch, which was scheduled for Thursday, via Chinese microblogging website Sina Weibo early Tuesday morning, citing a sudden attack of kidney stones.
At the launch of a 2018 China green bond market report in February, Sean Kidney, CEO of the non-government Climate Bonds Initiative, an international NGO, said: "China has been the global leader in regulatory measures to support green finance.
Sean Kidney, chief executive of the Climate Bonds Initiative, said the move signaled ICBC's intent to become the leading green credit bank in the world.
"We have an incredible challenge, globally, in addressing climate change and the environmental impact of pollution," Kidney said.
Sean Kidney, chief executive of the Climate Bonds Initiative, said the move signaled ICBC’s intent to become the leading green credit bank in the world.
“We have an incredible challenge, globally, in addressing climate change and the environmental impact of pollution,” Kidney said.